McKesson Corporation 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by McKesson Corporation on April 6, 2026, reporting events occurring on April 1, 2026. The filing details the entry into a new material definitive credit agreement by certain subsidiaries, including McKesson Medical-Surgical Top Holdings, Inc.
Key Financial Metrics and Debt Structure
The Company established new Senior Secured Credit Facilities totaling $2.0 billion in term loans and $1.0 billion in revolving credit. The filing does not provide current revenue, profit, cash flow, or margin data as this is a transactional report rather than a periodic financial statement.
- Term Loan A-1 Facility: $750.0 million, due 2031.
- Term Loan A-2 Facility: $250.0 million, due 2028.
- Revolving Credit Facility: $1,000.0 million, due April 1, 2031.
- Interest Rates (Term Loans): Adjusted Term SOFR + 1.250% or Base Rate + 0.250%.
- Interest Rates (Revolving): Initially Term Benchmark + 1.250% or Base Rate + 0.250%, subject to future adjustment based on leverage ratios and credit ratings.
- Commitment Fees: Ranging from 0.175% to 0.225% based on financial metrics.
Material Changes and Covenants
The primary material change is the creation of new direct financial obligations secured by substantially all tangible and intangible assets of the Borrower and certain material U.S. subsidiaries. The agreement includes standard affirmative and negative covenants restricting indebtedness, liens, investments, fundamental changes, dispositions, and dividends. Financial maintenance covenants require the maintenance of a maximum Total Net Leverage Ratio and a minimum Interest Coverage Ratio, tested quarterly.
Outlook, Risks, and Management Commentary
Management commentary is limited to the execution of the agreement. The filing notes that lenders and their affiliates may engage in future commercial or investment banking transactions with the Company. Risks associated with the agreement include compliance with financial covenants and the obligation to pay interest and fees based on variable rates and leverage ratios. No specific guidance or unusual items were disclosed in this filing.
Investor Verification Checklist
- Verify the full text of the Credit Agreement (Exhibit 10.1) for specific definitions of "Total Net Leverage Ratio" and "Interest Coverage Ratio."
- Confirm the impact of the new debt on the Company's overall leverage profile in the next quarterly report.
- Monitor future interest rate fluctuations given the reliance on SOFR and Term Benchmark rates.
- Review subsequent filings for any amendments to the covenants or changes in the Company's credit rating that would affect borrowing costs.